Approaches of 3D printing in current drug delivery

Three-dimensional printing (3DP) is predicted to be one of the most progressive innovations within the pharmacy. Nowadays, the use of 3D printing technologies in drug delivery systems has exponentially expanded, due to its potential advantages over customizing drugs in individually adjusted doses. 3...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Snehamayee Mohapatra, Rajat Kumar Kar, Prasanta Kumar Biswal, Sabitri Bindhani
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2022
Materias:
Acceso en línea:https://doaj.org/article/edb1d955c6b447fa9c24e0da42cd3648
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:edb1d955c6b447fa9c24e0da42cd3648
record_format dspace
spelling oai:doaj.org-article:edb1d955c6b447fa9c24e0da42cd36482021-11-22T04:31:07ZApproaches of 3D printing in current drug delivery2666-351110.1016/j.sintl.2021.100146https://doaj.org/article/edb1d955c6b447fa9c24e0da42cd36482022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S266635112100067Xhttps://doaj.org/toc/2666-3511Three-dimensional printing (3DP) is predicted to be one of the most progressive innovations within the pharmacy. Nowadays, the use of 3D printing technologies in drug delivery systems has exponentially expanded, due to its potential advantages over customizing drugs in individually adjusted doses. 3DP empowers the precise deposition of medicaments and excipients, which might cause a change in perspective in drug configuration, production, and use. It can span the medication improvement measure, from the preclinical turn of events and clinical preliminaries to frontline medical care. Though 3DP technology represents the clinical and financial advantages, some specialized and administrative challenges limit its utilization of pharmaceutical products. Accordingly, there's a prerequisite for constant development and refinement in 3DP methods to beat current limits and work with patients' particular medical services with the utilization of customized drugs in the future. This article presents a few 3DP technologies appropriate for drug fabrications with their applications in the improvement of the drug dose structures, demonstrating the feasibility of this innovation in regular commercial production with regulatory assessment.Snehamayee MohapatraRajat Kumar KarPrasanta Kumar BiswalSabitri BindhaniKeAi Communications Co., Ltd.articleThree-dimensional printing (3DP)Computer-aided designFused deposition modellingStereolithographyContinuous inkjet printingElectrical engineering. Electronics. Nuclear engineeringTK1-9971ENSensors International, Vol 3, Iss , Pp 100146- (2022)
institution DOAJ
collection DOAJ
language EN
topic Three-dimensional printing (3DP)
Computer-aided design
Fused deposition modelling
Stereolithography
Continuous inkjet printing
Electrical engineering. Electronics. Nuclear engineering
TK1-9971
spellingShingle Three-dimensional printing (3DP)
Computer-aided design
Fused deposition modelling
Stereolithography
Continuous inkjet printing
Electrical engineering. Electronics. Nuclear engineering
TK1-9971
Snehamayee Mohapatra
Rajat Kumar Kar
Prasanta Kumar Biswal
Sabitri Bindhani
Approaches of 3D printing in current drug delivery
description Three-dimensional printing (3DP) is predicted to be one of the most progressive innovations within the pharmacy. Nowadays, the use of 3D printing technologies in drug delivery systems has exponentially expanded, due to its potential advantages over customizing drugs in individually adjusted doses. 3DP empowers the precise deposition of medicaments and excipients, which might cause a change in perspective in drug configuration, production, and use. It can span the medication improvement measure, from the preclinical turn of events and clinical preliminaries to frontline medical care. Though 3DP technology represents the clinical and financial advantages, some specialized and administrative challenges limit its utilization of pharmaceutical products. Accordingly, there's a prerequisite for constant development and refinement in 3DP methods to beat current limits and work with patients' particular medical services with the utilization of customized drugs in the future. This article presents a few 3DP technologies appropriate for drug fabrications with their applications in the improvement of the drug dose structures, demonstrating the feasibility of this innovation in regular commercial production with regulatory assessment.
format article
author Snehamayee Mohapatra
Rajat Kumar Kar
Prasanta Kumar Biswal
Sabitri Bindhani
author_facet Snehamayee Mohapatra
Rajat Kumar Kar
Prasanta Kumar Biswal
Sabitri Bindhani
author_sort Snehamayee Mohapatra
title Approaches of 3D printing in current drug delivery
title_short Approaches of 3D printing in current drug delivery
title_full Approaches of 3D printing in current drug delivery
title_fullStr Approaches of 3D printing in current drug delivery
title_full_unstemmed Approaches of 3D printing in current drug delivery
title_sort approaches of 3d printing in current drug delivery
publisher KeAi Communications Co., Ltd.
publishDate 2022
url https://doaj.org/article/edb1d955c6b447fa9c24e0da42cd3648
work_keys_str_mv AT snehamayeemohapatra approachesof3dprintingincurrentdrugdelivery
AT rajatkumarkar approachesof3dprintingincurrentdrugdelivery
AT prasantakumarbiswal approachesof3dprintingincurrentdrugdelivery
AT sabitribindhani approachesof3dprintingincurrentdrugdelivery
_version_ 1718418196958019584